Actively Recruiting
Phase II Study of Intraperitoneal and Systemic Paclitaxel Chemotherapy for Gastrointestinal Cancers with Peritoneal Spread
Led by University of California, Irvine · Updated on 2026-08-31
55
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the feasibility of combining systemic and intraperitoneal chemotherapy in adults with gastrointestinal cancers who have peritoneal carcinomatosis, a condition where cancer has spread to the lining of the abdomen. This phase II open-label basket trial focuses on patients with confirmed primary digestive tract carcinomas. The study aims to understand how well this combined treatment can be administered and tolerated. Participants receive one of several chemotherapy regimens involving paclitaxel given both intraperitoneally and intravenously at two different schedules every two weeks or every three weeks. The study groups are divided based on cancer type, including gastric or gastroesophageal adenocarcinoma, colorectal or appendiceal adenocarcinoma, and other digestive tract adenocarcinomas. Each participant receives the assigned paclitaxel regimen alongside systemic therapy as part of their treatment. During the trial, participants will be closely monitored for treatment completion over six weeks, with long-term follow-up assessing overall survival and progression-free survival for up to three years. Quality of life and safety outcomes, including adverse events, are also evaluated up to one year. The study involves regular assessments to track response rate, side effects, and patient-reported outcomes to understand the impact and feasibility of this combined chemotherapy approach.
CONDITIONS
Brief Title
Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)
Research Team
C
Chao Family Comprehensive Cancer Center University of California, Irvine
U
University of California Irvine Medical
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here